biotech · Ovarian Clear Cell Carcinoma · Tumors · LIXT
LIXTE BIOTECHNOLOGY HOLDINGS
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXTE BIOTECHNOLOGY HOLDINGS clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
East Setauket, USA HQ
2006 Founded
7 Employees
Public company Type
LIXT · NYSE Ticker
Company details
- Status
- Public
- HQ
- East Setauket, USA
- Founded
- 2006
- Employees
- 7
- Programs
- 3
- Drugs
- 3
- Patents
- 26
LIXTE BIOTECHNOLOGY HOLDINGS projects
3 ClinicalTrials.gov programs sponsored by LIXTE BIOTECHNOLOGY HOLDINGS.
LIXTE BIOTECHNOLOGY HOLDINGS has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does LIXTE BIOTECHNOLOGY HOLDINGS have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.